TK-6302, a supercharged PRAME TCR-T cell therapy containing a high affinity TCR, an activating CD8 coreceptor (costimCD8 CoR) ...

As students return to school following spring break, Texas measles cases are continuing to grow with health officials warning ...

A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients ...

Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.

However, pediatric cancers present unique challenges due to their distinct immunosuppressive microenvironments. These microenvironments are characterized by the presence of suppressive cells like ...

Corticosteroids are used in pharmacologic doses for their anti-inflammatory and immunosuppressive properties. When corticosteroids are used for these purposes, the systemic agents with the least ...

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...

Sabki, Head of the General Authority for Health Care, met with Dr Samah Al-Bagouri, Chairman of the Board of Directors of ...

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...